GCP-unit at Aarhus University Hospital, Aarhus, Denmark
GCP-unit at Aarhus University Hospital, Aarhus, Denmark
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Topical JAK-Inhibition of Early-Stage CTCL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mycosis fungoides, neoplasm, primary cutaneous T-cell non-Hodgkin lymphoma | Not yet recruiting | Phase 2 | 2026-08-26 | NCT07781449 | |
| Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Active, not recruiting | Phase 3 | 2026-08-17 | NCT04688788 | |
| Reversal to Normoglycemia by Treating Prediabetes | Arterial Occlusive Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, diabetes mellitus, endocrine system disorder, eye disorder, glucose metabolism disease, heart disorder, kidney disorder, metabolic disease, myocardial ischemia, prediabetes syndrome, retinal disorder, urinary system disorder, vascular disorder | Not yet recruiting | Phase 3 | 2026-02-06 | NCT07392151 |